Skip to content

Clinical trials

Phase 1 Small Cell Lung Carcinoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1 Country / region: Spain Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20131
20141
20163
20175
20184
20194
20204
20211
20221
20234
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated8
Recruiting6
Active, not recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Amgen4
Hoffmann-La Roche4
AstraZeneca3
Boehringer Ingelheim2
Eli Lilly and Company2
GlaxoSmithKline2
Pfizer2
Aileron Therapeutics, Inc.1
BeiGene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma35
Carcinoma, Non-Small-Cell Lung17
Neoplasms9
Triple Negative Breast Neoplasms8
Ovarian Neoplasms7
Stomach Neoplasms6
Melanoma5
Uterine Cervical Neoplasms5
Carcinoma, Hepatocellular4
Carcinoma, Merkel Cell4

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.